Cardiac patient management at Guidant
This article was originally published in The Gray Sheet
Executive Summary
FDA approval of the Contak Renewal 3 RF cardiac resynchronization therapy defibrillator and Zoom Latitude programmer will allow physicians to use remote monitoring to evaluate patients at three times the interrogation speed of the firm's previous programmer. Guidant plans to introduce the technology in the U.S. in Q4. Medtronic markets the CardioSight data access tool to cardiologists whose patients have been implanted with a defibrillator such as the InSync Sentry (1"The Gray Sheet" Aug. 22, 2005, In Brief)...